KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | -25.0% | 15,431 | 0.0% | 0.00% | – |
| Q2 2023 | $28 | -31.7% | 15,431 | +46.0% | 0.00% | – |
| Q1 2023 | $41 | 0.0% | 10,571 | -12.0% | 0.00% | – |
| Q4 2022 | $41 | -99.9% | 12,012 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $66,000 | +24.5% | 12,012 | +1.6% | 0.00% | – |
| Q2 2022 | $53,000 | -38.4% | 11,818 | +0.8% | 0.00% | -100.0% |
| Q1 2022 | $86,000 | -47.6% | 11,722 | -53.9% | 0.00% | 0.0% |
| Q4 2021 | $164,000 | +115.8% | 25,424 | +94.7% | 0.00% | 0.0% |
| Q3 2021 | $76,000 | -45.7% | 13,061 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $140,000 | +32.1% | 13,596 | +35.0% | 0.00% | -75.0% |
| Q1 2021 | $106,000 | -37.6% | 10,074 | -8.1% | 0.00% | -33.3% |
| Q4 2020 | $170,000 | +6.9% | 10,962 | +0.6% | 0.01% | -14.3% |
| Q3 2020 | $159,000 | -25.4% | 10,901 | -2.9% | 0.01% | -30.0% |
| Q2 2020 | $213,000 | +4.9% | 11,228 | +6.2% | 0.01% | +100.0% |
| Q1 2020 | $203,000 | -2.4% | 10,574 | -2.8% | 0.01% | +25.0% |
| Q4 2019 | $208,000 | +110.1% | 10,874 | +6.0% | 0.00% | +100.0% |
| Q3 2019 | $99,000 | +59.7% | 10,258 | -0.7% | 0.00% | +100.0% |
| Q2 2019 | $62,000 | – | 10,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |